Chemicals for the net zero future

SYNTHETIC BIOLOGY

Synthetic Biology and AI are the main drivers of the next technological revolution, and we will leverage those tools to decarbonise key chemicals through the use of our novel cyanobacterial platform. By recreating the building blocks of our everyday economy, we will impact key industries and create the multiplier effect to make a tangible impact faster.

Deep Blue BioTech’s mission is to move synthetic biology from the lab to the marketplace.

Carbon Impact

Our Cyanobacteria technology platform is able to produce high-value chemicals that will replace their current fossil-derived alternatives in the market. These chemicals are mainly obtained through fossil fuels and attempts for alternative sources have failed due to cost constraints.

Our cost-effective solution will allow our chemicals to initially penetrate key industries like Pharma, Beauty and Personal Care, to eventually expand in other markets maximising our carbon mitigation potential.

Benefits of Synthetic Biology

Precision and Customisation

Synthetic biology enables precise design and engineering of microorganisms to produce tailored chemicals, optimizing yields, reducing waste, and enhancing efficiency.

Sustainability

Renewable feedstocks reduces fossil fuel dependency, lowers environmental impact by decreasing emissions, and fosters eco-friendly, biodegradable chemical development.

Rapid Development and Iteration

Synthetic biology speeds up biological system development, enabling rapid prototyping and innovation, reducing costs, and enhancing chemical industry processes.

What are Cyanobacteria?

Cyanobacteria, or blue-green algae, are potent allies in combating climate change. They are the most efficient photosynthetic organism on earth, absorbing CO2 and producing oxygen and glucose more efficiently than plants.

They excel in synthetic biology because they utilize CO2 as their primary feedstock, eliminating the need for arable land and actively contributing to carbon removal for climate change mitigation.

Harnessing this decarbonizing potential is crucial for tackling the climate crisis, and our team is committed to advancing cyanobacteria science.

Our Leadership Team

An accomplished team with expertise in synthetic biology, sustainable design, and scaling novel technologies, dedicated to pioneering innovative solutions for a net-zero future.

Manuel Rios, CEO

Manuel, a seasoned Business Leader and Strategist, boasts two decades of success at FMCG giants like Unilever. His expertise in Chemical and Environmental Engineering, coupled with a deep understanding of consumer needs, will drive the launch of the next generation of sustainable products.

Tim Corcoran, COO

Tim is a Business Development consultant by background. He specializes in crafting growth strategies, securing investors, partners, and clients for start-ups and scale-ups. His track record spans from inception to successful exits.

Dr. M. Lucia Burdisso, Chief Science Officer

Lucia brings over 10 years of interdisciplinary expertise in genetic engineering, assay development, and synthetic biology. With a strong background in microalgae and cyanobacteria research, she has driven innovation across academia and biotech startups, delivering impactful R&D projects with a global perspective.

Dr. Matt Proctor, Head of R&D

Matt obtained his PhD in Molecular Biology and Biotechnology at the University of Sheffield. He is an expert in cyanobacteria with a particular emphasis on the understanding and enhancing of photosynthesis towards developing new biology based carbon capture technologies.

Become part of the journey

Our focus on sustainable, carbon-neutral solutions not only makes us an industry leader but also offers strong returns for investors. Contact us to learn more about how your investment can contribute to a net zero future and yield financial growth.

Deep Blue Biotech (Logo)

Thank You!

You have been subscribed to our newsletter. You can opt out at any time by clicking the ‘unsubscribe’ link at the bottom of our emails.